-
-
-
Biogen's 2024 Financial Report
Financial statements
Biogen cuts four pipeline programs and secures a $1.8 billion deal with Royalty Pharma. Leqembi, its Alzheimer’s treatment, achieves $281M in global sales for 2024. Multiple sclerosis remains its top revenue driver amid a 2% overall revenue decline.
晋宁县|
蓝山县|
永泰县|
巴林左旗|
江达县|
荆门市|
靖州|
华容县|
西乌珠穆沁旗|
长垣县|
荃湾区|
驻马店市|
积石山|
靖安县|
个旧市|
乌审旗|
新乡市|
灵武市|
五寨县|
横峰县|
苍溪县|
深泽县|
集安市|
微山县|
临湘市|
永宁县|
肃南|
绥棱县|
上蔡县|
柳州市|
若尔盖县|
根河市|
富锦市|
遂昌县|
栾川县|
秭归县|
开江县|
炉霍县|
甘孜县|
奉节县|
镇远县|